People v. Stockman CA1/1

CourtCalifornia Court of Appeal
DecidedMarch 28, 2014
DocketA137286
StatusUnpublished

This text of People v. Stockman CA1/1 (People v. Stockman CA1/1) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
People v. Stockman CA1/1, (Cal. Ct. App. 2014).

Opinion

Filed 3/28/14 P. v. Stockman CA1/1 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIRST APPELLATE DISTRICT

DIVISION ONE

THE PEOPLE, Plaintiff and Respondent, A137286 v. GREGORY CHATTEN STOCKMAN, (Sonoma County Super. Ct. No. SCR20626) Defendant and Appellant.

In 1993, defendant Gregory Chatten Stockman was charged with attempted murder and assault with a deadly weapon. (Pen. Code, §§ 187 subd. (a), 664, 245, subd. (a)(1).)1 He was found not guilty by reason of insanity and committed to Napa State Hospital. Defendant appeals from an order denying him conditional release under section 1026.2 to a supervised outpatient program. We affirm. FACTUAL BACKGROUND This appeal is the latest in a series of disputes concerning defendant’s treatment and rehabilitation. Defendant has been diagnosed with Bipolar I Disorder, alcohol dependence, and Personality Disorder Not Otherwise Specified. On two occasions, from 2001–2003 and from 2004–2006, the state hospital authorized his conditional release on an outpatient basis.

1 All further statutory references are to the Penal Code unless otherwise indicated.

1 In 2006, the trial court revoked outpatient status because there was substantial evidence he needed inpatient treatment or had refused outpatient treatment and supervision. We affirmed this order in 2008 in a nonpublished opinion. (People v. Stockman (July 18, 2008, A117559).) As a result of the revocation order, the trial court ruled defendant was ineligible for a final-phase restoration-of-sanity trial. We also affirmed this order. (People v. Stockman (Nov. 25, 2008, A120518) [nonpub. opn.].) Recognizing that he needed to regain outpatient status as the first step in the restoration-of-sanity process, defendant, in 2009, sought outpatient status by application under section 1026.2. The trial court denied this application, crediting expert testimony defendant would be dangerous to others if released, because he had shown an unwillingness to comply with essential requirements of his treatment plan and was guarded and non-communicative with his treatment team. We concluded the court’s findings were supported by substantial evidence, and affirmed in 2010 in a nonpublished opinion. (People v. Stockman (Oct. 22, 2010, A126735).) Section 1026.2 allows successive applications for outpatient release or restoration of sanity, so long as the defendant waits a year after each denial. (§ 1026.2, subd. (j).) Defendant filed a new application on July 11, 2012. The trial court requested a current report from Napa State Hospital, which defendant submitted with his court filings. (See § 1026.2, subd. (l) [when application for outpatient release is by defendant, “no action on the application shall be taken by the court without first obtaining the written recommendation of the medical director of the state hospital or other treatment facility”]; see also People v. Sword (1994) 29 Cal.App.4th 614, 635–636 [court may consider medical records of committee, despite hearsay concerns].) According to the report, defendant “should be retained for treatment, as he has a severe mental illness, continues to be a danger to others, and therefore cannot be treated in a lower level of care or a less secure facility at this time.”

2 Although the report noted no incidents of verbal or behavioral aggression and no major relapse since defendant’s initial offense, and also noted other positive developments (such as defendant having previously held a job at the hospital and defendant’s new willingness to share information about his financial transactions), the report also catalogued a number of concerns. For instance, defendant, despite medication, exhibits some residual symptoms of his disorder, including “paranoia and some obsessive qualities”; defendant’s most recent doctor, Dr. Sachdeb, found defendant had poor judgment and an unwillingness to follow his treatment plan; defendant was not compliant with conditions when previously an outpatient and he presently was refusing to meet with certain staff who handle the outpatient release program; and defendant was recently relocated from an “open unit” to a “closed” or “locked” unit after refusing to take Abilify, which had been prescribed (in addition to the Lithium he was already taking for the bipolar disorder) to reduce the “paranoid symptoms related to his mental illness that lead him to be excessively guarded and interfere with his treatment.” According to the report, his unwillingness to cooperate in his treatment, as most seriously and recently evidenced by his refusal to take Abilify, indicates “he may not cooperate with his treatment team if he is placed in community supervision.” His “excessive guardedness creates uncertainty that he will openly share symptoms with his team, making it harder to ensure they will be able to provide the optimal treatment to prevent future decompensation and the much higher risk level that such a decompensation would entail.” Further, the treatment team views defendant’s unwillingness to cooperate as a risk factor for dangerous behavior. The court held a hearing on defendant’s section 1026.2 application over three days in November 2012. Five witnesses testified. Dr. Eugene Roeder, retained by defendant, reviewed defendant’s records and interviewed defendant. He opined defendant would not be a danger to others if placed on outpatient release. He believed defendant would continue to take his Lithium. Although

3 prescription of medications was beyond Dr. Roeder’s expertise, he was allowed to offer his opinion that defendant’s refusal to take Abilify would not increase defendant’s danger to society. Yet Dr. Roeder testified medication noncompliance, with Lithium in particular, would be a marker of dangerousness. Further, Dr. Roeder believed some of the hospital-imposed “compliance” conditions, such as the requirement that defendant disclose a particular loan transaction from 2006, did not relate to dangerousness, even if an uptick in spending could be, in general, a marker for relapse. Dr. Anita Sachdeb, a psychiatrist from Napa State Hospital, treated defendant during the four to five months prior to his most recent application. She confirmed Abilify was prescribed—and recommended by three different doctors—to address defendant’s guarded, suspicious, and paranoid behavior, and elaborated that Abilify also treats Bipolar I Disorder and it was hoped Abilify might address residual symptoms the Lithium had not completely addressed. She also testified defendant had problems while in the community before 1993 staying on Lithium, although there had not been a problem with Lithium since. She also noted an incident in 2007 when defendant refused Risperdal. The failure to take Abilify was a “really important criteria” and the “main concern.” Even if he might continue to take Lithium as an outpatient, he would almost certainly not take Abilify or other similar drugs prescribed by his doctors. According to Dr. Sachdeb, defendant was having ongoing trouble confiding in his treatment team and they had difficulty knowing what was going on inside his head. A lack of transparency could “lead to a lot of problems” and the missing of warning signs of impending danger. Ultimately, Dr. Sachdeb concluded defendant would be dangerous if not in the hospital environment and he stopped taking his medications. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

People v. Wende
600 P.2d 1071 (California Supreme Court, 1979)
People v. Williams
198 Cal. App. 3d 1476 (California Court of Appeal, 1988)
People v. Rasmuson
52 Cal. Rptr. 3d 598 (California Court of Appeal, 2006)
People v. Sword
29 Cal. App. 4th 614 (California Court of Appeal, 1994)
Kelly v. CB&I CONSTRUCTORS, INC.
179 Cal. App. 4th 442 (California Court of Appeal, 2009)
People v. Bartsch
167 Cal. App. 4th 896 (California Court of Appeal, 2008)
People v. Soiu
131 Cal. Rptr. 2d 421 (California Court of Appeal, 2003)
People v. Cross
25 Cal. Rptr. 3d 186 (California Court of Appeal, 2005)
People v. Beck
47 Cal. App. 4th 1676 (California Court of Appeal, 1996)
People v. Dobson
75 Cal. Rptr. 3d 238 (California Court of Appeal, 2008)
People v. Geier
161 P.3d 104 (California Supreme Court, 2007)
People v. McDonough
196 Cal. App. 4th 1472 (California Court of Appeal, 2011)
People v. Gregerson
202 Cal. App. 4th 306 (California Court of Appeal, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
People v. Stockman CA1/1, Counsel Stack Legal Research, https://law.counselstack.com/opinion/people-v-stockman-ca11-calctapp-2014.